Prematür Ejakülasyonda Ürolojik Yaklaşım
Özet
Prematür ejakülasyon (PE), erkeklerde en sık görülen cinsel işlev bozukluklarından biri olup ejakülasyon süresinin kısalığı, ejakülasyon kontrolünde azalma ve buna bağlı psikolojik sıkıntı ile karakterizedir. Güncel yaklaşım, hastalığın yalnızca kısa intravajinal ejakülasyon latans süresi ile değil, bireysel ve ilişkisel etkileriyle birlikte değerlendirilmesini önermektedir. PE, yaşam boyu ve kazanılmış olmak üzere iki ana gruba ayrılmakta olup etiyolojisinde nörobiyolojik, psikolojik, genetik ve ilişkisel faktörler birlikte rol oynamaktadır. Tanı büyük ölçüde ayrıntılı anamnez, semptom değerlendirmesi ve gerekli durumlarda doğrulanmış ölçeklerin kullanımı ile konulmaktadır. Kazanılmış olgularda erektil disfonksiyon, hipertiroidi ve kronik prostatit gibi altta yatan nedenlerin araştırılması önemlidir. Tedavide davranışsal yöntemler, psikoseksüel danışmanlık ve farmakolojik ajanlar birlikte değerlendirilmektedir. Seçici serotonin geri alım inhibitörleri, özellikle dapoksetin, etkinliği en güçlü kanıtlarla desteklenen tedavi seçenekleri arasında yer almaktadır. Topikal anestezikler ve erektil disfonksiyonun eşlik ettiği hastalarda fosfodiesteraz tip 5 inhibitörleri uygun olgularda kullanılabilmektedir. Bireyselleştirilmiş ve multidisipliner tedavi yaklaşımı, ejakülasyon kontrolü, cinsel memnuniyet ve yaşam kalitesinde anlamlı iyileşme sağlamaktadır.
Referanslar
McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, et al. An evidence- based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. The journal of sexual medicine. 2008;5(7):1590-606.
Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. Jama. 1999;281(6):537-44.
Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, et al. Development and validation of a premature ejaculation diagnostic tool. European urology. 2007;52(2):565-73.
Althof SE, McMahon CG, Waldinger MD, Serefoglu EC, Shindel AW, Adaikan PG, et al. An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). Sexual medicine. 2014;2(2):60-90.
Waldinger MD. Lifelong premature ejaculation: From authoritybased to evidencebased medicine. BJU international. 2004;93(2):201-7.
Rowland DL, Patrick DL, Rothman M, Gagnon DD. The psychological burden of premature ejaculation. The Journal of urology. 2007;177(3):1065-70.
Rosen RC, Althof S. Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. The journal of sexual medicine. 2008;5(6):1296-307.
Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidities, and professional help- seeking. European urology. 2007;51(3):816-24.
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. The journal of sexual medicine. 2005;2(4):492-7.
McMahon CG. Premature ejaculation. Indian J Urol. 2007;23(2):97-108.
Althof SE. Psychological approaches to the treatment of rapid ejaculation. The Journal of Men’s Health and Gender. 2006;3(2):180-6.
Waldinger MD. Premature ejaculation: different pathophysiologies and etiologies determine its treatment. Journal of sex & marital therapy. 2007;34(1):1-13.
Corona G, Petrone L, Mannucci E, Jannini E, Mansani R, Magini A, et al. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. European urology. 2004;46(5):615-22.
McCabe M, Althof SE, Assalian P, Chevret-Measson M, Leiblum SR, Simonelli C, et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med. 2010;7(1 Pt 2):327-36.
Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo-and hyperthyroid patients. The Journal of Clinical Endocrinology & Metabolism. 2005;90(12):6472-9.
Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology. 2001;58(2):198-202.
Giuliano F, Clément P. Physiology of ejaculation: emphasis on serotonergic control. European Urology. 2005;48(3):408-17.
Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behavioural brain research. 1998;92(2):111-8.
Waldinger MD, Olivier B. Animal models of premature and retarded ejaculation. World Journal of Urology. 2005;23(2):115-8.
Janssen PK, Bakker SC, Réthelyi J, Zwinderman AH, Touw DJ, Olivier B, et al. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. The journal of sexual medicine. 2009;6(1):276-84.
Xin ZC, Chung WS, Choi YD, Seong DH, Choi YJ, Choi HK. Penile sensitivity in patients with primary premature ejaculation. The Journal of urology. 1996;156(3):979-81.
Shin DH, Spitz A. The evaluation and treatment of delayed ejaculation. Sexual medicine reviews. 2014;2(3-4):121-33.
Shindel AW, Akhavan A, Sharlip ID. Urologic aspects of HIV infection. Medical Clinics. 2011;95(1):129-51.
Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sexual medicine. 2014;2(2):41-59.
Stefania Di Sante M, Gianfrilli D, Lombardo F, Lenzi A. Premature ejaculation: old story, new insights. 2015.
Althof SE, McMahon CG, Rowland DL. Advances and missteps in diagnosing premature ejaculation: analysis and future directions. The journal of sexual medicine. 2022;19(1):64-73.
Urology EAo. Arnhem, The Netherlands: EAU Guidelines Office; 2026 [Presented at the EAU Annual Congress London 2026:[
Semans JH. Premature ejaculation: a new approach. Southern Medical Journal. 1956;49(4):353- 7.
Cooper K, MartynSt James M, Kaltenthaler E, Dickinson K, Cantrell A, Wylie K, et al. Behavioral therapies for management of premature ejaculation: a systematic review. Sexual Medicine. 2015;3(3):174-88.
Althof SE. Psychosexual therapy for premature ejaculation. Translational andrology and urology. 2016;5(4):475.
McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Therapeutic advances in urology. 2012;4(5):233-51.
Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. The lancet. 2006;368(9539):929-37.
Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol. 2009;55(4):957-67.
McMahon CG. Treatment of premature ejaculation with dapoxetine. Premature Ejaculation: From Etiology to Diagnosis and Treatment: Springer; 2012. p. 241-62.
Pattij T, Olivier B, Waldinger M. Animal models of ejaculatory behavior. Current pharmaceutical design. 2005;11(31):4069-77.
Pu C, Yang L, Liu L, Yuan H, Wei Q, Han P. Topical anesthetic agents for premature ejaculation: a systematic review and meta-analysis. Urology. 2013;81(4):799-804.
Henry R, Morales A. Topical lidocaine–prilocaine spray for the treatment of premature ejaculation: a proof of concept study. International journal of impotence research. 2003;15(4):277-81.
Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. The Journal of urology. 2002;168(6):2486-9.